1. Home
  2. MREO vs JILL Comparison

MREO vs JILL Comparison

Compare MREO & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • JILL
  • Stock Information
  • Founded
  • MREO 2015
  • JILL 1959
  • Country
  • MREO United Kingdom
  • JILL United States
  • Employees
  • MREO N/A
  • JILL N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • JILL Clothing/Shoe/Accessory Stores
  • Sector
  • MREO Health Care
  • JILL Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • JILL Nasdaq
  • Market Cap
  • MREO 281.6M
  • JILL 233.1M
  • IPO Year
  • MREO N/A
  • JILL 2017
  • Fundamental
  • Price
  • MREO $1.79
  • JILL $18.17
  • Analyst Decision
  • MREO Strong Buy
  • JILL Buy
  • Analyst Count
  • MREO 5
  • JILL 3
  • Target Price
  • MREO $7.40
  • JILL $18.00
  • AVG Volume (30 Days)
  • MREO 1.2M
  • JILL 120.3K
  • Earning Date
  • MREO 08-12-2025
  • JILL 09-03-2025
  • Dividend Yield
  • MREO N/A
  • JILL 1.78%
  • EPS Growth
  • MREO N/A
  • JILL N/A
  • EPS
  • MREO N/A
  • JILL 2.39
  • Revenue
  • MREO $500,000.00
  • JILL $601,713,000.00
  • Revenue This Year
  • MREO N/A
  • JILL $1.16
  • Revenue Next Year
  • MREO $55.50
  • JILL $1.46
  • P/E Ratio
  • MREO N/A
  • JILL $7.54
  • Revenue Growth
  • MREO N/A
  • JILL N/A
  • 52 Week Low
  • MREO $1.47
  • JILL $13.36
  • 52 Week High
  • MREO $4.72
  • JILL $30.40
  • Technical
  • Relative Strength Index (RSI)
  • MREO 52.86
  • JILL 66.54
  • Support Level
  • MREO $1.68
  • JILL $15.97
  • Resistance Level
  • MREO $1.83
  • JILL $18.38
  • Average True Range (ATR)
  • MREO 0.08
  • JILL 0.82
  • MACD
  • MREO 0.03
  • JILL 0.15
  • Stochastic Oscillator
  • MREO 82.61
  • JILL 92.03

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About JILL J. Jill Inc.

J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.

Share on Social Networks: